Fortress Biotech Inc (FBIO)

NASDAQ

$3.33

Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.

This company is also listed under the following ticker: FBIOP.

Website: https://www.fortressbiotech.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $11 (+230.33%)

Market Cap

$123M

P/B Ratio

0.77

Profit Margin

193.1%

P/E Ratio

0.95

Price Chart

Adjust inflation

Log

Valuation

Market Cap$123M

P/E0.95

Forward P/E1.40

P/S1.87

P/B0.77

Profitability

Total Revenue (TTM)$64M

Gross Profit (TTM)$35M

EBITDA-$55M

Profit Margin193.1%

Operating Margin-48.6%

EPS$3.91

Financial Health

Debt-to-Equity23.1%

Growth & Risk

Revenue 5Y CAGR+8.13%

Beta (5Y)0.87

Sharpe Ratio1.04